Sean Stevens, PhD

Sean Stevens, PhD

Chief Scientific Officer

Dr. Sean Stevens serves as the Chief Scientific Officer of KBio and brings more than 20 years of experience designing, optimizing, and implementing complex platforms with the goal of delivering biologics and cell-based therapeutics across disease states. Prior to his KBio appointment, Dr. Stevens served as Vice President of the Lung Biotechnology subsidiary of United Therapeutics. Previously, he served as Vice President of both Synthetic Genomics Inc. and Ablexis. Earlier in his career, Dr. Stevens held research positions at both AnaptysBio, Inc., and Regeneron Pharmaceuticals, Inc.

Scroll to Top